Global brokerages remained selective on large-cap stocks following the latest round of quarterly earnings, with Citi reiterating its bullish view on Sun Pharma and Morgan Stanley backing Maruti Suzuki despite trimming estimates. Meanwhile, Motilal Oswal maintained a cautious stance on ITC amid continued pressure on its cigarette business.